These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29866840)

  • 21. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.
    Grassilli S; Brugnoli F; Lattanzio R; Marchisio M; Perracchio L; Piantelli M; Bavelloni A; Capitani S; Bertagnolo V
    Mol Oncol; 2018 Jun; 12(7):1012-1025. PubMed ID: 29658179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
    Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
    Zhong J; Chen YJ; Chen L; Shen YY; Zhang QH; Yang J; Cao RX; Zu XY; Wen GB
    Oncol Rep; 2017 Aug; 38(2):1303-1311. PubMed ID: 28677794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.
    Costa RLB; Han HS; Gradishar WJ
    Breast Cancer Res Treat; 2018 Jun; 169(3):397-406. PubMed ID: 29417298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on correlation between PKIB and pAkt expression in breast cancer tissues.
    Zhang JB; Song W; Wang YY; Liu MG; Sun MM; Liu H
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1264-1269. PubMed ID: 28387904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKIB promotes cell proliferation and the invasion-metastasis cascade through the PI3K/Akt pathway in NSCLC cells.
    Dou P; Zhang D; Cheng Z; Zhou G; Zhang L
    Exp Biol Med (Maywood); 2016 Nov; 241(17):1911-1918. PubMed ID: 27325557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H; Pan H; Qian Y; Zhou W; Liu X
    Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
    Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
    Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro.
    Lee E; Jin D; Lee BB; Kim Y; Han J; Shim YM; Kim DH
    BMC Cancer; 2015 Dec; 15():982. PubMed ID: 26681199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer.
    Li D; Yang Y; Zhu G; Liu X; Zhao M; Li X; Yang Q
    FEBS Lett; 2015 Aug; 589(17):2218-23. PubMed ID: 26149213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
    Zhong J; Cao RX; Liu JH; Liu YB; Wang J; Liu LP; Chen YJ; Yang J; Zhang QH; Wu Y; Ding WJ; Hong T; Xiao XH; Zu XY; Wen GB
    Oncogene; 2014 Nov; 33(48):5546-58. PubMed ID: 24292672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
    Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.